CASE REPORT

Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous oestrogen used for infertility treatment

S Yano

Department of Pulmonary Medicine, National Matsue Hospital, 5-8-31, Agenogi, Matsue City, Shimane 690-8556, Japan; yano{at}matsue.hosp.go.jp

Pulmonary lymphangioleiomyomatosis (LAM) is a rare disease that affects women in the reproductive years. It is occasionally associated with tuberous sclerosis, especially in the incomplete form. As it is likely that oestrogen plays a central role in disease progression, exogenous oestrogen will cause a deterioration in LAM. However, the early stage of this disease is easy to miss unless the physician is a specialist. Although there have been some reports in menopausal women given exogenous oestrogen for osteoporosis, this is the first report of pulmonary LAM caused by exogenous oestrogen used for the treatment of infertility.

Keywords: lymphangioleiomyomatosis (LAM); tuberous sclerosis complex; exogenous oestrogen

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Harari, S., Cassandro, R., Chiodini, J., Taveira-DaSilva, A. M., Moss, J. (2008). Effect of a Gonadotrophin-Releasing Hormone Analogue on Lung Function in Lymphangioleiomyomatosis. Chest 133: 448-454 [Abstract] [Full Text]  
• Johnson, S. R. (2006). Lymphangioleiomyomatosis.. Eur Respir J 27: 1056-1065 [Abstract] [Full Text]  
• Ryu, J. H., Moss, J., Beck, G. J., Lee, J.-C., Brown, K. K., Chapman, J. T., Finlay, G. A., Olson, E. J., Ruoss, S. J., Maurer, J. R., Raffin, T. A., Peavy, H. H., McCarthy, K., Taveira-DaSilva, A., McCormack, F. X., Avila, N. A., DeCastro, R. M., Jacobs, S. S., Stylianou, M., Fanburg, B. L., for the NHLBI LAM Registry Group, (2006). The NHLBI Lymphangioleiomyomatosis Registry: Characteristics of 230 Patients at Enrollment. Am. J. Respir. Crit. Care Med. 173: 105-111 [Abstract] [Full Text]  
• Taveira-DaSilva, A. M., Stylianou, M. P., Hedin, C. J., Hathaway, O., Moss, J. (2005). Bone Mineral Density in Lymphangioleiomyomatosis. Am. J. Respir. Crit. Care Med. 171: 61-67 [Abstract] [Full Text]  
• Taveira-DaSilva, A. M., Stylianou, M. P., Hedin, C. J., Hathaway, O., Moss, J. (2004). Decline in Lung Function in Patients With Lymphangioleiomyomatosis Treated With or Without Progesterone. Chest 126: 1867-1874 [Abstract] [Full Text]  
• Whale, C I, Johnson, S R, Phillips, K G, Newton, S A, Lewis, S A, Tattersfield, A E (2003). Lymphangioleiomyomatosis: a case-control study of perinatal and early life events. Thorax 58: 979-982 [Abstract] [Full Text]